May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

January 08, 2025

Modified Consent May Aid Psychedelic Trials

Researchers at the University of California, San Francisco propose modifications to informed consent procedures in psychedelic drug trials, aiming to balance scientific rigor and ethical standards.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

February 11, 2025

Copper, Iron Levels Tied to Fibromyalgia

A Mendelian randomization study of 400,000 individuals revealed elevated copper increases risk while iron shows protective effects against fibromyalgia.

Conexiant

December 16, 2024

Arthritis Drugs Linked to Fracture Risk

Current gabapentinoid use in patients with inflammatory arthritis was associated with a 36% higher odds of fractures compared to remote use, with risks persisting across most dose levels and showing marked impact shortly after drug initiation.

Conexiant

September 03, 2024

Pain and Demographic Factors Drive Symptom Severity in Long COVID

A retrospective case series study aimed to define the most commonly reported symptoms associated with long COVID.

Conexiant

June 26, 2024

FDA Releases Guidance for Drugmakers on Diversity in Clinical Studies

The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.

Conexiant